Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
Arcturus Therapeutics Holdings Inc. (ARCT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
8-K
| Quarterly results |
05/09/2023 |
8-K
| Quarterly results |
11/09/2022 |
8-K
| Quarterly results |
08/09/2022 |
8-K
| Quarterly results |
05/09/2022 |
8-K
| Quarterly results |
02/28/2022 |
8-K
| Quarterly results |
11/08/2021 |
8-K
| Quarterly results |
05/10/2021 |
8-K
| Quarterly results |
11/09/2020 |
8-K
| Quarterly results |
08/10/2020 |
8-K
| Quarterly results |
05/07/2020 |
8-K
| Quarterly results
Docs:
|
"ARCTURUS THERAPEUTICS HOLDINGS INC. AND ITS SUBSIDIARIES CONSOLIDATED BALANCE SHEETS March 31, 2020 December 31, 2019 Assets Current assets: Cash and cash equivalents $ 59,471 $ 71,353 Accounts receivable 2,351 2,179 Prepaid expenses and other current assets 1,937 758 Total current assets 63,759 74,290 Property and equipment, net 2,571 2,349 Operating lease right-of-use asset, net 5,567 5,134 Equity-method investment 100 263 Non-current restricted cash 107 107 Total assets $ 72,104 $ 82,143 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 3,779 $ 5,793 Accrued liabilities 9,775 7,134 Deferred revenue 8,096 8,397 Total current liabilities 21,650 21,324 Deferred revenue, net of current portion 13,815 15,182 Long-term debt 15,028 14,995 Operating lease liability, n..." |
|
11/07/2019 |
8-K
| Quarterly results |
|
|